OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
September 10, 2021
Vector Laboratories has completed a $124 million cash buyout backed by Thompson Street Capital Partners and will begin an acquisition strategy to expand protein detection capabilities.
September 02, 2021
Establishing analytical workflows for complex biopharmaceutical molecules can help predict their risk of degradation.
August 26, 2021
A new membrane staining kit, ExoBrite, launched by Biotium aims to enhance the detection of exosomes through flow cytometry.
BioMed X has partnered with Janssen to start two new research programs for autoimmune diseases and drug delivery.
August 09, 2021
The guidance aids in the development, validation, and use of near infrared-based analytical procedures.
August 02, 2021
Growing demand for bispecific antibodies increases the need for automated and miniaturized high throughput screening capabilities.
August 01, 2021
Automation is one asset that benefits cell harvesting by cutting out laborious manual steps and minimizing contamination.
Correct organization and appropriate methods for demonstrating biosimilar comparability are important for supporting regulatory filings.
July 29, 2021
Thermo Fisher Scientific has added a new suite of immune repertoire assays that offers high detection rates of malignant clones, allowing researchers to better assess blood cancers.
July 16, 2021
The ever-increasing complexity of biotherapeutic molecules presents unique analytical challenges for developers.